Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys. Author(s): Larremore DB, Fosdick BK, Bubar KM, Zhang S, Kissler SM, Metcalf CJE, Buckee C, Grad YH|Journal: Elife|PMID: 33666169| March 2021 Establishing how many people have been infected by SARS-CoV-2 remains an urgent priority for controlling the COVID-19 pandemic. Serological tests…
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Author(s): Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB|Journal: Science|PMID: 33479118| January 2021 Limited initial supply of SARS-CoV-2 vaccine raises the question of how to prioritize available doses. Here, we used a mathematical…
Implications of test characteristics and population seroprevalence on ‘immune passport’ strategies. Author(s): Larremore DB, Bubar KM, Grad YH|Journal: Clin Infect Dis|PMID: 32687149| July 2020 Various forms of 'immune passports' or 'antibody certificates' are being considered in conversations around reopening economies after periods of social…
